Browse Category

Health Insurance News 29 January 2026 - 7 February 2026

UnitedHealth stock rebounds after hours as UNH recoups losses; Medicare rate debate looms

UnitedHealth stock rebounds after hours as UNH recoups losses; Medicare rate debate looms

UnitedHealth shares rose 3.4% to $277.57 Friday and gained another 3% after hours, rebounding after a volatile week for health insurers. Mizuho cut its price target on the stock to $350, citing delayed earnings recovery. Medicare Advantage rates and medical-cost trends remain key concerns. The Dow closed above 50,000, marking the strongest market gains in months.
Oscar Health (OSCR) stock slips again in premarket as insurer cost fears spread ahead of earnings

Oscar Health (OSCR) stock slips again in premarket as insurer cost fears spread ahead of earnings

Oscar Health shares fell 2.3% to $12.22 in premarket trading Friday after a 5.4% drop Thursday, as investors reacted to Molina Healthcare’s profit warning and exit from Medicare Part D. Molina’s stock plunged nearly 35% after hours, dragging other managed-care stocks lower. Oscar reports earnings Feb. 10, with investors watching for updates on 2026 enrollment and claims.
UnitedHealth stock slips in premarket after Mizuho cuts target, as Medicare Advantage pressure builds

UnitedHealth stock slips in premarket after Mizuho cuts target, as Medicare Advantage pressure builds

UnitedHealth shares fell 2.7% to $268.55 in premarket trading after Mizuho cut its price target to $350. The move follows regulatory scrutiny over Medicare Advantage payments and pharmacy benefit manager practices. Investors are watching the Feb. 25 CMS comment deadline and an April rate decision. Other managed-care stocks showed mixed premarket moves.
UnitedHealth stock slips after hours — here’s what could move UNH next

UnitedHealth stock slips after hours — here’s what could move UNH next

UnitedHealth shares fell 2.7% to $268.55 Thursday, with little change after hours, as investors reacted to Medicare Advantage reimbursement proposals. The Centers for Medicare & Medicaid Services set a Feb. 25 comment deadline and will announce final 2027 rates by April 6. UnitedHealth projected 2026 revenue above $439 billion, down from 2025 estimates. CEO Tim Noel called the proposed rate “disappointing.”
Cigna stock jumps as earnings beat meets soft 2026 outlook and FTC insulin settlement

Cigna stock jumps as earnings beat meets soft 2026 outlook and FTC insulin settlement

Cigna shares rose 3.2% to $280.46 after posting Q4 adjusted earnings of $8.08 per share, above forecasts, though its 2026 outlook missed estimates. Express Scripts agreed to a 10-year FTC settlement on insulin pricing, expected to cut patient costs by up to $7 billion. Evernorth pharmacy revenue jumped 20% to $36.3 billion. Cigna’s board raised its quarterly dividend to $1.56 per share.
UnitedHealth stock price slides 3% as Optum pricing study and FTC pressure keep UNH in focus

UnitedHealth stock price slides 3% as Optum pricing study and FTC pressure keep UNH in focus

UnitedHealth shares fell about 3% Wednesday, closing at $275.58, after a Cornell study linked Optum’s surgery-center acquisitions to an 11% price hike in commercial claims. Investors are watching for Medicare Advantage rate decisions in April amid ongoing regulatory scrutiny of UnitedHealth’s Optum and other managed-care firms.
UnitedHealth stock slips after hours as Optum price-study and fresh target cuts keep UNH in focus

UnitedHealth stock slips after hours as Optum price-study and fresh target cuts keep UNH in focus

UnitedHealth shares fell 0.5% to $284.18 in after-hours trading Tuesday after JPMorgan and Truist cut price targets, citing uncertainty over Medicare Advantage rates. A new study found surgery center prices rose 11% after Optum acquisitions, increasing scrutiny of UnitedHealth’s provider deals.
UnitedHealth stock slips again as Truist, JPMorgan trim targets and Medicare Advantage rates loom

UnitedHealth stock slips again as Truist, JPMorgan trim targets and Medicare Advantage rates loom

UnitedHealth shares fell about 1.2% to $282.20 by midday Tuesday after Truist and JPMorgan cut their price targets to $370 and $389, respectively. Investors cited concerns over Medicare Advantage payment changes and rising medical costs. UnitedHealth recently projected 2026 revenue above $439 billion with adjusted earnings expected to top $17.75 per share.
UnitedHealth stock bounces even after Truist, JPMorgan trim targets as Medicare Advantage rates loom

UnitedHealth stock bounces even after Truist, JPMorgan trim targets as Medicare Advantage rates loom

UnitedHealth shares rose 1% to $289.75 Monday, outperforming peers as Humana, Elevance, and Cigna declined. Truist and JPMorgan cut price targets but kept positive ratings. Investors focused on Medicare Advantage payment rates and 2026 cost trends after last week’s sector sell-off. Final 2027 Medicare Advantage rates are expected in April.
UnitedHealth stock slips again after Barclays trims target — here’s what traders are watching next

UnitedHealth stock slips again after Barclays trims target — here’s what traders are watching next

UnitedHealth shares fell 1.8% to $286.93 in after-hours trading Friday after Barclays cut its price target. The stock has dropped about 18% since Monday, triggered by a 20% plunge Tuesday. UnitedHealth forecast 2026 revenue just over $439 billion, down 2% from last year, and signaled a medical care ratio of 88.8%. Several banks trimmed price targets this week, citing Medicare-related uncertainty.
UnitedHealth stock dips again as Medicare Advantage rate worries hang over UNH shares

UnitedHealth stock dips again as Medicare Advantage rate worries hang over UNH shares

UnitedHealth Group shares fell 2.1% to $286.12 in late-morning trading Friday, extending losses after this week’s selloff. Investors focused on proposed 2027 Medicare Advantage payment changes, with the government’s comment period ending Feb. 25 and final rates due April 6. CMS projects a net average payment increase of 0.09% for 2027. UBS cut its price target for UnitedHealth to $410, citing rate uncertainty.
Elevance Health stock rises as ELV steadies after cautious 2026 outlook and Medicare rate jitters

Elevance Health stock rises as ELV steadies after cautious 2026 outlook and Medicare rate jitters

Elevance Health shares rose 1% to $345.44 Thursday, leading gains in managed-care stocks after policy and earnings volatility. The company forecast 2026 adjusted EPS of at least $25.50, below analyst expectations, and warned of revenue declines amid Medicaid and ACA headwinds. Medicare Advantage payments are set for a minimal 0.09% increase in 2027, rattling the sector. ACA enrollment for 2026 dropped to about 23 million as subsidies ended.
1 2 3 7

Stock Market Today

Seagate (STX) stock jumps nearly 6% as Citi hikes target — what to watch next week

Seagate (STX) stock jumps nearly 6% as Citi hikes target — what to watch next week

7 February 2026
Seagate shares rose 5.9% to $429.32 Friday after Citigroup raised its price target to $480 and reiterated a buy rating. The gain ended a two-day slide but left the stock 6.6% below its Feb. 3 high. CEO Dave Mosley sold 20,000 shares on Feb. 2 under a pre-arranged plan, SEC filings show. U.S. jobs and inflation data next week are seen as key tests for tech stocks.
Cummins (CMI) stock price rebounds after earnings whipsaw as investors eye data-center power demand

Cummins (CMI) stock price rebounds after earnings whipsaw as investors eye data-center power demand

7 February 2026
Cummins shares jumped 6.8% to $577.73 Friday, recovering from a nearly 9% post-earnings drop the day before. The company reported Q4 revenue up 1% to $8.54 billion, took a $218 million charge tied to its hydrogen business, and guided for 2026 EBITDA of 17–18% of sales. Demand for data center generators offset weakness in North American truck markets. Analyst reaction was mixed; Truist raised its price target.
Corning stock hits first record close since 2000 as jobs, CPI data loom

Corning stock hits first record close since 2000 as jobs, CPI data loom

7 February 2026
Corning shares surged 8.3% to $122.16 Friday, their highest close since the dot-com era, after Meta agreed to buy up to $6 billion in fiber-optic cables. The stock is up 40% since late 2025, fueled by strong first-quarter guidance and AI data-center demand. Insiders sold shares following the rally, SEC filings show. Investors await next week’s U.S. jobs and inflation data for rate signals.
Go toTop